Here’s what you need to know.
1. Director of the F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute at Cedars-Sinai and lead investigator Stephan Targan, MD, said the study is the “longest IBD study of its kind funded by the NIH and the first to explore the genetic makeup of the disease.”
2. The study started in 1992. Researchers have used molecular signatures to identify the several different types of IBD.
3. Dermot McGovern, MD, PhD, professor of Medicine and Biomedical Sciences and director of Cedars-Sinai Precision Health, said the project “is making very significant contributions to helping patients around the world.”
4. By establishing the molecular signatures, it positions researchers towards developing treatments for the disease to “finally bring relief and healing to many patients,” Dr. Targan said.
More articles on gastroenterology/endoscopy:
AGA releases animated video for GERD education: 3 highlights
Invendo receives CE Mark for sterile, single-use endoscope: 5 things you need to know
Allergan settles with Zydus and Cadila over Delzicol: 4 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.